DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
RE-NOVATE Study Group:. Eriksson BI, Dahl OE, Rosencher N. et al.
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized, double-blind, non-inferiority trial.
Lancet 2007;
370: 949-956.
We do not assume any responsibility for the contents of the web pages of other providers.